Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8.
Watanabe S, Yoshikawa T, Kaku Y, Kurosu T, Fukushi S, Sugimoto S, Nishisaka Y, Fuji H, Marsh G, Maeda K, Ebihara H, Morikawa S, Shimojima M, Saijo M. Watanabe S, et al. Among authors: fukushi s. PLoS Negl Trop Dis. 2023 Dec 15;17(12):e0011851. doi: 10.1371/journal.pntd.0011851. eCollection 2023 Dec. PLoS Negl Trop Dis. 2023. PMID: 38100536 Free PMC article.
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants.
Moriyama S, Anraku Y, Taminishi S, Adachi Y, Kuroda D, Kita S, Higuchi Y, Kirita Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y. Moriyama S, et al. Among authors: fukushi s. Nat Commun. 2023 Jul 14;14(1):4198. doi: 10.1038/s41467-023-39890-8. Nat Commun. 2023. PMID: 37452031 Free PMC article.
Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate.
Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Imai M, Koga M, Yamamoto S, Adachi E, Saito M, Tsutsumi T, Otani A, Fukushi S, Watanabe S, Suzuki T, Kikuchi T, Yotsuyanagi H, Maeda K, Kawaoka Y. Uraki R, et al. Among authors: fukushi s. iScience. 2023 Oct 4;26(11):108147. doi: 10.1016/j.isci.2023.108147. eCollection 2023 Nov 17. iScience. 2023. PMID: 37876803 Free PMC article.
Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA.
Yamasaki M, Saso W, Yamamoto T, Sato M, Takagi H, Hasegawa T, Kozakura Y, Yokoi H, Ohashi H, Tsuchimoto K, Hashimoto R, Fukushi S, Uda A, Muramatsu M, Takayama K, Maeda K, Takahashi Y, Nagase T, Watashi K. Yamasaki M, et al. Among authors: fukushi s. Antiviral Res. 2024 Oct;230:105992. doi: 10.1016/j.antiviral.2024.105992. Epub 2024 Aug 23. Antiviral Res. 2024. PMID: 39181215
Inactivation of SARS-CoV-2 in Serum Using Physical Methods.
Harada T, Fujimoto H, Fukushi S, Ishii K, Hanaki KI. Harada T, et al. Among authors: fukushi s. Jpn J Infect Dis. 2024 Jul 23;77(4):201-204. doi: 10.7883/yoken.JJID.2023.349. Epub 2024 Jan 31. Jpn J Infect Dis. 2024. PMID: 38296541 Free article.
Successful treatment of acyclovir-resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T-cell prolymphocytic leukemia.
Kawamura Y, Uchibori N, Arakawa T, Fujii T, Negishi S, Morikawa S, Fukushima N, Kohno A, Yamada S, Fukui Y, Fukushi S, Ozeki K. Kawamura Y, et al. Among authors: fukushi s. EJHaem. 2024 Apr 29;5(3):616-619. doi: 10.1002/jha2.899. eCollection 2024 Jun. EJHaem. 2024. PMID: 38895086 Free PMC article.
CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes.
Onodera T, Sax N, Sato T, Adachi Y, Kotaki R, Inoue T, Shinnakasu R, Nakagawa T, Fukushi S, Terooatea T, Yoshikawa M, Tonouchi K, Nagakura T, Moriyama S, Matsumura T, Isogawa M, Terahara K, Takano T, Sun L, Nishiyama A, Omoto S, Shinkai M, Kurosaki T, Yamashita K, Takahashi Y. Onodera T, et al. Among authors: fukushi s. Sci Adv. 2023 Jun 16;9(24):eadf0661. doi: 10.1126/sciadv.adf0661. Epub 2023 Jun 14. Sci Adv. 2023. PMID: 37315144 Free PMC article.
Improved efficacy of SARS-CoV-2 isolation from COVID-19 clinical specimens using VeroE6 cells overexpressing TMPRSS2 and human ACE2.
Kinoshita H, Yamamoto T, Kuroda Y, Inoue Y, Miyazaki K, Ohmagari N, Tokita D, Nguyen PHA, Yamada S, Harada S, Kanno T, Takahashi K, Saito M, Shirato K, Takayama I, Watanabe S, Saito T, Ebihara H, Suzuki T, Maeda K, Fukushi S. Kinoshita H, et al. Among authors: fukushi s. Sci Rep. 2024 Oct 22;14(1):24858. doi: 10.1038/s41598-024-75038-4. Sci Rep. 2024. PMID: 39438626 Free PMC article.
234 results